Keyword: King Pharmaceuticals
Two drugmakers have admitted to sharing "commercially sensitive" information to keep prices high in the U.K.
Alllergan is suing Pfizer, saying it needs to indemnify it for claims tied to opioid drug Kadian.
A Pfizer deal is at the center of another round of insider trading charges. This time, the buyout is Pfizer’s 2010 King Pharmaceuticals deal, and it’s a lawyer who allegedly told secrets.